A little pre-weekend treat, just for you: A complimentary look at the latest picks from our Strong Buy Stocks from Top Wall Street Analysts screener:
-
Delta Air Lines (DAL) gets an upgrade on earnings beat news
- Why Zymeworks (ZYME) could deliver double-digit gains in the coming year
-
Ibex (IBEX) is our latest Stock of the Week — find out why
P.S. Get more alerts like this daily … Try WallStreetZen Premium.
A note from our sponsors...
Sell Nvidia and replace it with WHAT?!
The AI trade is running full throttle. But it won't last forever. It's not time to abandon AI stocks completely, but it IS time to prepare for the inevitable slowdown.
Futurist Eric is giving away 7 free trade ideas in his "Sell This, Buy That" research package, where he reveals which market moves you need to make today (starting with getting rid of Nvidia stock.)
Access these trade ideas here.
1. Delta Air Lines (NYSE: DAL)
A veritable industry giant, Delta is one of the largest airlines in the United States. The company delivered a solid beat in Q3 2025 — as a result, Wall Street analysts have gone on a barrage of price target hikes. The best part? DAL is incredibly cheap right now — but it might not stay that way for long.
Zen Rating: B (Buy) — see full analysis >
Recent Price: $57.48 — get current quote >
Max 1-year forecast: $90.00
Why we’re watching:
- DAL enjoys broad, bullish support from Wall Street equity researchers — the stock currently has 9 Strong Buy ratings and 2 Buy ratings. See the ratings
- The average 12-month price forecast for Delta Air Lines shares currently stands at $73.91, and implies a hefty 28.58% upside.
- Raymond James’s Savanthi Syth (a top 12% rated analyst) doubled down on a Strong Buy rating on the stock following the company’s Q3 2025 earnings and hiked her price target from $68 to $70.
- According to Syth, "momentum in domestic main cabin improvement and continued overall premium strength" helped the company kick off Q3 earnings season with a beat and raise.
- The analyst said that Delta Air Lines has structural advantages over its older peers.
-
Thomas Wadewitz of UBS also reiterated a Strong Buy rating, and increased his price forecast from $72 to $75.
- Looking ahead, Wadewitz told readers that stock price upside is supported by improving sales and management's positive Q4 guidance.
- Delta Air Lines is the 2nd highest-rated stock in the Airline industry, which has an Industry Rating of B.
- DAL has a Zen Rating of B, and currently ranks in the top 7% of the equities that we track.
- Per its Artificial Intelligence Component Grade rating, Delta Air Lines ranks in the top 10% of stocks.
- When it comes to Value, DAL ranks in the 91st percentile, as the stock is trading at a price-to-earnings (P/E) ratio of just 8.05x.
-
Lastly, we have Sentiment, a category in which Delta Air Lines ranks in the top 8%, owing to the fact that 12% of the insider transactions tied to the stock in the past 12 months have been purchases. (See all 7 Zen Component Grades here >)

Zymeworks is a clinical-stage biopharmaceutical company focused on improving the efficacy and safety of cancer treatments. The company develops programs both in-house and through partnerships with major pharma players — so it enjoys a broad and diverse pipeline. However, the main draw here is quite specific — and it has to do with the smart money crowd.
Zen Rating: A (Strong Buy) — see full analysis >
Recent Price: $18.06 — get current quote >
Max 1-year forecast: $30.00
Why we’re watching:
- Zymeworks stock currently has 2 Strong Buy ratings and 1 Hold rating from Wall Street analysts. See the ratings
- With that being said, the average price target for ZYME shares, currently at $21.67, implies a hefty 19.97% upside, and paints a much more bullish picture.
-
Mayank Mamtani of B. Riley Securities (a top 4% rated analyst) recently initiated coverage on the stock with a Strong Buy rating and a Street-high $30 price target.
- The other Strong Buy rating comes from Citigroup’s Yigal Nochomovitz (a top 9% rated analyst), who set a $22 price target on the stock.
- ZYME ranks in the top 5% of the stocks that we track, giving it a Zen Rating of A, which has historically corresponded to an average annual return of 32.52%.
- In terms of its Growth Component Grade rating, Zymeworks ranks in the 96th percentile of equities.
- However, the stock’s most pronounced Component Grade rating is Sentiment — where it ranks in the top 1%. That might have something to do with the fact that a whopping 98.19% of the insider transactions tied to the stock in the past 12 months have been purchases. (See all 7 Zen Component Grades here >)

Ibex is an up-and-coming customer experience outsourcer that serves a variety of industries. It’s also our Stock of the Week. IBEX had a strong rally after a recent earnings beat, but has since gone down to a bargain price — and our Editor-in-Chief believes the stock could see prices increase by 35% by the end of the year if the company manages to extend its already impressive earnings beat streak.
Zen Rating: A (Strong Buy) — see full analysis >
Recent Price: $36.84 — get current quote >
Max 1-year forecast: $39.00
Why we’re watching:
- IBEX is our Stock of the Week. Our Editor-in-Chief, Steve Reitmeister, explained why he added it to his exclusive 20-stock strong Zen Investor portfolio in a Monday article.
- At the moment, large caps are, generally speaking, quite overvalued — in contrast, small-cap stocks like Ibex tend to have more upside potential
- The stock has a Zen Rating of A, and is actually ranked 3rd overall out of the roughly 4,600 equities that we track.
- After a recent earnings beat, IBEX shares rocketed up to $43 — having since receded back down to the mid $30’s, now is an opportune time to Buy the Dip.
- If the beat and raise cycle continues, our Editor-in-Chief believes that IBEX could reach prices as high as $50 by the end of the year, and possibly double its current price by the end of 2026.
- IBEX has some pretty compelling scores in terms of its Component Grade ratings. The stock ranks in the top 25% for Growth and the top 22% for Safety.
- In addition, Ibex shares rank in the top 10% with regard to the Momentum Component Grade rating.
- IBEX is also the top-rated stock in the Information Technology Service industry, which has an Industry Rating of B.
- Despite being a relatively low-profile stock, IBEX has attracted attention from the Smart Money crowd, as it ranks in the top 7% when it comes to Sentiment.
- Ibex stock is currently trading at an attractive P/E ratio of 14.68x and an even more attractive PEG ratio of just 0.56x — so it’s little wonder that it ranks in the 97th percentile according to Value.
-
Last, but certainly not least is the company’s impressive balance sheet — which has placed IBEX in the top 1% of stocks in terms of Financials. (See all 7 Zen Component Grades here >)

What to Do Next?